-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Amrize, Raises Price Target to $66

Benzinga·02/19/2026 14:53:28
Listen to the news
Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Overweight and raises the price target from $59 to $66.